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The e x c i t a t i o n  f u n c t i o n s  of proton-induced n u c l e a r  I n  a d d i t i o n ,  a number of ruthenium compounds have 
r e a c t i o n s  f o r  f o u r  r a d i o n u c l i d e s  o f  v a l u e  i n  n u c l e a r  shown promise a s  u s e f u l  a g e n t s  i n  cancer  chemotherapy. 
1 
medicine have been measured. Cross s e c t i o n s  of 9 7 ~ u  The convenient  h a l f - l i f e  of 9 6 ~ c  ( 4 . 3  d) makes i t  a 
and 9 6 ~ c  formed i n  rhodium t a r g e t s  a s  w e l l  a s  1 0 9 ~ d  and v a l u a b l e  t r a c e r  f o r  developing new rad iopharmaceut ica l s  
l13sn  formed i n  indium t a r g e t s  have been determined f o r  t h e  s h o r t - l i v e d  i s o t o p e ,  9 9 m ~ c  (6.02 h) , which 
f o r  p ro ton  e n e r g i e s  from 60 t o  200 MeV. These d a t a  h a s  found e x t e n s i v e  a p p l i c a t i o n  i n  n u c l e a r  medicine. 2 
w i l l  p rov ide  a b a s i s  f o r  s e l e c t i n g  op t imal  i r r a d i a t i o n  
c o n d i t i o n s  and c a l c u l a t i n g  t h i c k - t a r g e t  y i e l d s  f o r  
l a r g e - s c a l e  p r e p a r a t i o n s  a t  t h e  Brookhaven Linac I s o -  
tope  Producer (BLIP). 
The c r o s s  s e c t i o n s  have been determined by ac- 
t i v a t i o n  of t a r g e t s  fol lowed by Ge(Li) gamma-ray count- 
i n g  of t h e  a c t i v i t i e s .  No chemical s e p a r a t i o n s  were 
performed. I r r a d i a t i o n s  were c a r r i e d  ou t  i n  t h e  i s o -  
tope  produc t ion  f a c i l i t y  a t  IUCF. The beam c u r r e n t s  
were monitored w i t h  a Faraday cup. A f t e r  i r r a d i a t i o n  
t h e  samples were shipped t o  BNL f o r  counting.  S e v e r a l  
of t h e s e  r e s u l t s  a r e  shown i n  F igs .  l a - l b  along w i t h  
A l i c e  Hybrid c a l c u l a t i o n s  performed by D r .  H. Karwowski. 
Aside from some d i sc repancy  a t  lower e n e r g i e s ,  t h e  over- 
a l l  shapes of t h e  e x c i t a t i o n  f u n c t i o n s  and g e n e r a l  
magnitude a r e  reproduced. 
The elements ,  9 7 ~ u ,  9 6 ~ c ,  l o 9 c d ,  and l 1 3 s n ,  a r e  
of c o n s i d e r a b l e  i n t e r e s t  f o r  biomedical  and o t h e r  ap- 
p l i c a t i o n s .  Because of i ts d e s i r a b l e  p h y s i c a l  charac-  Ep (MeV) 
t e r i s t i c s  ( t  = 2.9 d ,  86% 216 keV gammas) and h igh  
Figure la .  Total cross section for the  production o f  
chemical r e a c t i v i t y  , 9 7 ~ u  is  a p o t e n t i a l  r a d i o n u c l i d e  3 6 ~ c  by proton bombardment of  rhodium. A comparison 
t o  Alice Hybrid caZcuZations i s  shorn. The curves are 
f o r  n u c l e a r  medicine a p p l i c a t i o n s  t o  n u c l e a r  oncology. a guide t o  the  eye. 
The element, lo9cd (tl12 = 453 d), is in equilibrium 
with its daughter, 109m~g (tlI2 = 40 s), which emits 
a single 88 keV gamma-ray (3.92% abundant). It is 
useful as an X-ray fluorescence or radiography source. 
The nuclear properties of the 109~d-109m~g pair also 
satisfy the requirements for a generator system which 
would provide a continuous source of ultrashort-lived 
medical nuclide for repeated dynamic studies . The 
parent nuclide for the important generator 
m 
system is 13sn (tl12 = 114.9 d) . The 113 in genera- 
tor has been shown to be of value in many nuclear imag- 
ing applications .4 The desirable characteristics of 
m 113 In include a short half-life of 1.658 h, a mono- 
energetic gamma emission of 392 keV (65% abundant), 
and no beta emissions to contribute to the radiation 
dosage. 
The Brookhaven Linac Isotope Producer (BLIP) ' €I 
has been in active use for the past few years for 
preparing large quantities of radionuclides of medical 
interest. It utilizes the excess beam capacity of a 
200-MeV proton Linac that injects protons into the 
Alternating Gradient Synchrotron, a 33-GeV accelerator 
used in high-energy physics research. The Linac can 
generate up to 10 pulses of 200-MeV protons per second, 
providing beam currents of 70 to 100 microamperes for 
radionuclide production. Preparations of clinically 
useful quantities of 9 7 ~ u  and 9 6 ~ c  from a rhodium 
target, and lo9cd and 3 ~ n  from an indium target at 
the BLIP have been demonstrated to be feasible. 
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Gpre 1b. Total cross section for the production of 
Ru by proton bombardment of  rhodiwn. The curves are 
explained i n  Fig. la. 
